Sort
16,179 grants matching “malaria”
Pharmacological insights into antimalarial exposure, clinical outcomes, and drug resistance in Africa
$727,306Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2021 · AI
Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
$727,267Jonathan Boyd Parr · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda
$727,201Jeffrey A. Bailey · Brown University · R01 · FY2022 · AI
Lead Optimization of DHODH Inhibitors for Malaria
$726,917Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2021 · AI
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR
$726,469Virginia Polytechnic Inst And St Univ · U01 · FY2004 · TW
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR
$726,467Virginia Polytechnic Inst And St Univ · U01 · FY2005 · TW
Midgut mitochondrial function as a driver of resistance and fitness in mosquitoes
$726,380Michael Allen Riehle · University Of Arizona · R56 · FY2018 · AI
Evaluating the role of P53 pathways in malaria
$726,260Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2024 · AI
Functional Biology Of T Cells
$726,148Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Analysis of Host-Pathogen Interactions
$726,148Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
VIOLIN 2.0: Vaccine Information and Ontology LInked kNowledgebase
$725,992Yongqun He · University Of Michigan At Ann Arbor · U24 · FY2025 · AI
Fosinopril analogs for the treatment of human babesiosis
$725,898Choukri Ben Mamoun · Yale University · R01 · FY2022 · AI
Fosinopril analogs for the treatment of human babesiosis
$725,898Choukri Ben Mamoun · Yale University · R01 · FY2023 · AI
Fosinopril analogs for the treatment of human babesiosis
$725,898Choukri Ben Mamoun · Yale University · R01 · FY2024 · AI
Fosinopril analogs for the treatment of human babesiosis
$725,898Choukri Ben Mamoun · Yale University · R01 · FY2025 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$725,877David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Importation and transmission of malaria in Zanzibar: a case study for elimination
$725,478Jonathan J Juliano · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Intervening to Improve Birth Weight and Infant Respiratory Health in Rural Ghana
$725,300Patrick Lott Kinney · Columbia University Health Sciences · R01 · FY2011 · ES
Orally Bioavailable 4(1H)-Quinolones with Multi-Stage Antimalarial Activity
$725,226Roman Manetsch · Northeastern University · R01 · FY2019 · AI
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
$725,059David Serre · University Of Maryland Baltimore · R01 · FY2023 · AI
Optimization of antimalarials targeting multiple life stages of the parasite
$724,987Paul R Carlier · University Of Illinois At Chicago · R01 · FY2022 · AI
Mechanisms of effective antibody neutralization
$724,692Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Structural characterization of host-pathogen interactions
$724,692Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria
$724,615Jonathan D. Kurtis · Brown University · R01 · FY2017 · AI
Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
$724,281Jonathan Boyd Parr · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI